Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Memorial Sloan-Kettering Cancer Center Insider Profile
4 Followers
Memorial Sloan-Kettering Cancer Center, Ten Percent Owner at Actinium Pharmaceuticals, holds 5.70M shares in Actinium Pharmaceuticals (Ticker: ATNM). Most recently, Memorial Sloan-Kettering Cancer Center Sold $192,927 shares of Actinium Pharmaceuticals on Sep 01, 2016 for an estimated value of 352.36K.
Memorial Sloan-Kettering Cancer Center Actinium Pharmaceuticals (ATNM)Ten Percent Owner
Actinium Pharmaceuticals (ATNM)
Ten Percent Owner
Ranked #1,689 out of 98,743 Corporate Insiders
Profitable Transactions
14 out of 14 Profitable Transactions
Average Return
+37.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Memorial Sloan-Kettering Cancer Center's holdings
Insider Roles
Ten Percent Owner
Roles that Memorial Sloan-Kettering Cancer Center holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 30, 2016 - Aug 30, 2017
Return:+64.60%
The most profitable trade made by Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center's Trading History
List of latest transactions for each holding click on a transaction to see Memorial Sloan-Kettering Cancer Center's performance on stock
You May Also Like
Memorial Sloan-Kettering Cancer Center insider profile FAQ
What is the percentage of profitable transactions made by Memorial Sloan-Kettering Cancer Center?
The percentage of profitable transactions made by Memorial Sloan-Kettering Cancer Center is 100%.
What is the average return per transaction made by Memorial Sloan-Kettering Cancer Center?
The average return per transaction made by Memorial Sloan-Kettering Cancer Center is 37.80%.
What stocks does Memorial Sloan-Kettering Cancer Center hold?
Memorial Sloan-Kettering Cancer Center holds: ATNM stocks.
What was Memorial Sloan-Kettering Cancer Center’s latest transaction?
Memorial Sloan-Kettering Cancer Center latest transaction was an Informative Sell of $352.36K.
What was Memorial Sloan-Kettering Cancer Center's most profitable transaction?
Memorial Sloan-Kettering Cancer Center’s most profitable transaction was an Informative Sell of ATNM stock on August 30, 2016. The return on the trade was 64.60%.
What is Memorial Sloan-Kettering Cancer Center's role in Actinium Pharmaceuticals?
Memorial Sloan-Kettering Cancer Center's role in Actinium Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.